期刊文献+

奥扎格雷钠治疗冠心病不稳定型心绞痛的疗效观察 被引量:1

下载PDF
导出
摘要 目的:观察奥扎格雷钠治疗冠心病不稳定型心绞痛的临床疗效。方法:将60例不稳定型心绞痛患者随机分成两组,治疗组30例,对照组30例,两组均给予阿司匹林、硝酸酯类药物、ACEI类药物、β受体阻滞剂或钙离子拮抗剂、他汀类药物等常规治疗,治疗组在对照组基础上加用奥扎格雷钠注射液80mg,每日1次静脉滴注,15天后观察临床疗效、心电图改善情况及不良反应等。结果:奥扎格雷钠可缓解心绞痛及心电图缺血改变。结论:在常规治疗基础上辅以奥扎格雷钠能有效治疗不稳定型心绞痛。
作者 王启斌
出处 《现代医药卫生》 2009年第7期1019-1020,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献5

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 2高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2005:158.
  • 3胡大一 马长生.心脏病学实践[M].北京:人民卫生出版社,2002.311.
  • 4霍勇..强化以阿司匹林为基础的抗血小板治疗[J]..中国医学论坛报,,2005,31(17):32..
  • 5刘靖..阿司匹林“抵抗”及处理策略[J]..中国医学论坛报,,2005,31(38):26..

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2321

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部